Miromatrix Medical Inc. (MIRO) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Eden Prairie, MN, United States. The current CEO is Jeffrey James Ross.
MIRO has IPO date of 2021-06-24, 76 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $92.95M.
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
